bf/NASDAQ:RNAZ_icon.jpeg

NASDAQ:RNAZ

TransCode Therapeutics

  • Stock

USD

Last Close

0.88

17/05 20:00

Market Cap

476.80K

Beta: -

Volume Today

3.90M

Avg: 1.67M

PE Ratio

−0.06

PFCF: −0.23

Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
revenue
cost of revenue
42.47K
-
98.61K
132.18%
516.75K
424.05%
gross profit
-42.47K
-
-98.61K
132.18%
-516.75K
424.05%
selling and marketing expenses
-7.15B
-
general and administrative expenses
230.56K
-
442.14K
91.77%
3.40M
668.34%
8.43M
148.25%
7.15B
84,740.58%
selling general and administrative expenses
230.56K
-
442.14K
91.77%
3.40M
668.34%
8.43M
148.25%
6.64M
21.29%
research and development expenses
226.31K
-
284.46K
25.69%
2.75M
868.14%
10.23M
271.55%
12.26M
19.85%
other expenses
-278.33K
-
-1.08M
288.18%
cost and expenses
456.87K
-
726.60K
59.04%
5.87M
708.25%
17.59M
199.44%
19.42M
10.42%
operating expenses
456.87K
-
726.60K
59.04%
5.87M
708.25%
17.59M
199.44%
18.90M
7.49%
interest expense
156.97K
-
394.57K
151.38%
95.07K
75.91%
17.56M
18,375.83%
-55.90M
418.24%
ebitda
-456.83K
-
-726.47K
59.02%
-5.83M
702.47%
-17.47M
199.61%
-18.90M
8.22%
operating income
-456.87K
-
-726.60K
59.04%
-6.15M
746.56%
-18.67M
203.45%
-19.42M
4.03%
depreciation and amortization
34
-
136
300%
321.47K
236,272.79%
1.20M
273.12%
516.75K
56.92%
total other income expenses net
-150.35K
-
-1.62M
975.70%
-692.26K
57.20%
1.10M
259.02%
872.42K
20.75%
income before tax
-607.21K
-
-2.34M
286.01%
-6.84M
191.97%
-17.56M
156.67%
-18.55M
5.59%
income tax expense
156.93K
-
394.44K
151.34%
95.07K
75.90%
17.56M
18,375.83%
4
100.00%
net income
-764.14K
-
-2.74M
258.35%
-6.94M
153.38%
-35.13M
406.31%
-18.55M
47.21%
weighted average shs out
16.13K
-
16.13K
0%
16.13K
0%
16.22K
0.56%
179.01K
1,003.54%
weighted average shs out dil
16.13K
-
16.13K
0%
16.13K
0%
16.22K
0.56%
179.01K
1,003.54%
eps
-47.37
-
-169.77
258.39%
-430.16
153.38%
-2.17K
403.47%
-103.61
95.22%
epsdiluted
-47.37
-
-169.77
258.39%
-430.16
153.38%
-2.17K
403.47%
-103.61
95.22%

All numbers in USD (except ratios and percentages)